Unerwünschte Arzneimittelwirkungen in der Gerontopsychiatrie

Zusammenfassung

Ziel der Studie war es zu überprüfen, ob die Verordnung „potenziell inadäquater Wirkstoffe“ (PIW) mit einem erhöhten Risiko für unerwünschte Arzneimittelwirkungen (UAW) einhergeht.

Methodik 304 stationäre gerontopsychiatrische Patienten wurden in die Studie eingeschlossen. Anhand der klinischen Daten und Verlaufsdokumentationen wurden Hinweise auf UAW identifiziert. Der Kausalzusammenhang der UAW und der verordneten Wirkstoffe wurde von Experten bewertet.

Ergebnisse Vor der stationären Aufnahme erhielten ca. 30 % aller Patienten ≥ 1 PIW, bei Entlassung waren es 22 %. Risikofaktoren für die Verordnung ≥ 1 PIW waren zunehmende Anzahl verordneter Wirkstoffe und Schizophrenie. Protektiv wirkten daher die Faktoren Demenz und zunehmendes Lebensalter. Die Verordnung von ≥ 1 PIW führte zu einem 5-fach erhöhten Risiko für das Auftreten von ≥ 1 UAW; das Risiko für UAW stieg mit der Zahl der PIW. Die Verordnung von ≥ 1 PIW ging mit einem 4-fach erhöhten Risiko für das Auftreten schwerwiegender UAW einher. Bei Einnahme von ≥ 2 PIW war das Risiko hierfür sogar um ein 10-Faches erhöht.

Schlussfolgerungen Die PRISCUS-Liste bildet wesentliche Risiken für das Auftreten von UAW in der Gerontopsychiatrie ab.

Abstract

Objective The purpose of this study was to examine the extent to which “potentially inappropriate drugs” (PID) are associated with an increased risk for adverse drug reactions (ADR).

Methods Data from 304 geriatric psychiatric inpatients was collected. Medical documentation was used to find indications of ADRs. Causal relationship between the ADR and the prescribed drugs was assessed by experts.

Results Almost 30 % of patients received ≥ 1 PID before admission to hospital, in comparison to 22 % at discharge. Increasing number of total prescriptions and the diagnosis of schizophrenia resulted in an increased risk for receiving ≥ 1 PID. Higher age and dementia were protective factors. Patients receiving ≥ 1 PID had a 5-fold increased risk of experiencing ≥ 1 ADR. Risk for an ADR increased with number of PID prescriptions. Patients treated with ≥ 1 PID had a 4-fold increased risk of experiencing severe ADRs. Risk for severe ADRs was 10-fold higher in patients treated with ≥ 2 PIDs.

Conclusion The PRISCUS list predicts significant risk factors for the occurrence of ADRs in the geriatric psychiatric setting.

Schlüsselwörter

potenziell inadäquate Medikation (PIM) - PRISCUS - unerwünschte Arzneimittelwirkung (UAW) - Arzneimitteltherapiesicherheit - Gerontopsychiatrie

Keywords

potentially inappropriate medication (PIM) - PRISCUS - adverse drug reaction (ADR) - drug safety - geriatric psychiatry

^* geteilte Letztautorenschaft

Publikationsverlauf

Artikel online veröffentlicht:
27. März 2021

• Literatur

• 1 Hilmer SN, McLachlan AJ, Le Couteur DG. Clinical pharmacology in the geriatric patient. Fundam Clin Pharmacol 2007; 21: 217-230
• 2 Haen ESM, Pascucci G. Potentiell inadäquate Medikationen (PIM). In: Klein H-GHE. Hrsg. Pharmakogenetik und Therapeutisches Durg Monitoring: Diagnostische Bausteine für die individualisierte Therapie. Berlin/Bosten: Walter de Gruyter GmbH; 2018
• 3 Panel BtAGSBCUE. American Geriatrics Society 2019 Updated AGS Beers Criteria^® for Potentially Inappropriate Medication Use in Older Adults. J Am Geriatr Soc 2019; 67: 674-694
• 4 Holt S, Schmiedl S, Thürmann PA. Potenziell inadäquate Medikation für ältere Menschen. Dtsch Arztebl Int 2010; 107: 543-551
• 5 Reich O, Rosemann T, Rapold R. et al. Potentially inappropriate medication use in older patients in Swiss managed care plans: prevalence, determinants and association with hospitalization. PLoS One 2014; 9: e105425
• 6 Endres HG, Kaufmann-Kolle P, Steeb V. et al. Association between Potentially Inappropriate Medication (PIM) Use and Risk of Hospitalization in Older Adults: An Observational Study Based on Routine Data Comparing PIM Use with Use of PIM Alternatives. PLoS One 2016; 11: e0146811
• 7 Henschel F, Redaelli M, Siegel M. et al. Correlation of Incident Potentially Inappropriate Medication Prescriptions and Hospitalization: An Analysis Based on the PRISCUS List. Drugs Real World Outcomes 2015; 2: 249-259
• 8 Heider D, Matschinger H, Meid AD. et al. The impact of potentially inappropriate medication on the development of health care costs and its moderation by the number of prescribed substances. Results of a retrospective matched cohort study. PloS one 2018; 13: e0198004-e04
• 9 Hyttinen V, Jyrkka J, Saastamoinen LK. et al. Patient- and health care-related factors associated with initiation of potentially inappropriate medication in community-dwelling older persons. Basic Clin Pharmacol Toxicol 2019; 124: 74-83
• 10 Holt S, Schmiedl S, Thurmann PA. Potentially inappropriate medications in the elderly: the PRISCUS list. Dtsch Arztebl Int 2010; 107: 543-551
• 11 Nebeker JR, Barach P, Samore MH. Clarifying adverse drug events: a clinicianʼs guide to terminology, documentation, and reporting. Ann Intern Med 2004; 140: 795-801
• 12 Haen E. Qualitätssicherung in der Psychopharmakotherapie. NeuroTransmitter 2004; 7/8: 34-43
• 13 Naranjo CA, Busto U, Sellers EM. et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981; 30: 239-245
• 14 Adams MA, Conway TL. Eta Squared. In: Michalos AC. ed. Encyclopedia of Quality of Life and Well-Being Research. Dordrecht: Springer Netherlands; 2014: 1965-1966
• 15 Stock S, Redaelli M, Simic D. et al. Risk factors for the prescription of potentially inappropriate medication (PIM) in the elderly: an analysis of sickness fund routine claims data from Germany. Wien Klin Wochenschr 2014; 126: 604-612
• 16 Dalleur O, Spinewine A, Henrard S. et al. Inappropriate prescribing and related hospital admissions in frail older persons according to the STOPP and START criteria. Drugs Aging 2012; 29: 829-837
• 17 Stuck AE, Beers MH, Steiner A. et al. Inappropriate medication use in community-residing older persons. Arch Intern Med 1994; 154: 2195-2200
• 18 Price SD, Holman CD, Sanfilippo FM. et al. Association between potentially inappropriate medications from the Beers criteria and the risk of unplanned hospitalization in elderly patients. Ann Pharmacother 2014; 48: 6-16
• 19 Wucherer D, Eichler T, Hertel J. et al. Potentially Inappropriate Medication in Community-Dwelling Primary Care Patients who were Screened Positive for Dementia. J Alzheimers Dis 2017; 55: 691-701
• 20 Kristensen RU, Nørgaard A, Jensen-Dahm C. et al. Polypharmacy and Potentially Inappropriate Medication in People with Dementia: A Nationwide Study. J Alzheimers Dis 2018; 63: 383-394
• 21 Sköldunger A, Fastbom J, Wimo A. et al. Impact of Inappropriate Drug Use on Hospitalizations, Mortality, and Costs in Older Persons and Persons with Dementia: Findings from the SNAC Study. Drugs Aging 2015; 32: 671-678
• 22 Fick DM, Mion LC, Beers MH. et al. Health outcomes associated with potentially inappropriate medication use in older adults. Res Nurs Health 2008; 31: 42-51
• 23 Hamilton H, Gallagher P, Ryan C. et al. Potentially inappropriate medications defined by STOPP criteria and the risk of adverse drug events in older hospitalized patients. Arch Intern Med 2011; 171: 1013-1019
• 24 Cahir C, Bennett K, Teljeur C. et al. Potentially inappropriate prescribing and adverse health outcomes in community dwelling older patients. Br J Clin Pharmacol 2014; 77: 201-210
• 25 Passarelli MC, Jacob-Filho W, Figueras A. Adverse drug reactions in an elderly hospitalised population: inappropriate prescription is a leading cause. Drugs Aging 2005; 22: 767-777
• 26 Bradley MC, Fahey T, Cahir C. et al. Potentially inappropriate prescribing and cost outcomes for older people: a cross-sectional study using the Northern Ireland Enhanced Prescribing Database. Eur J Clin Pharmacol 2012; 68: 1425-1433
• 27 Onder G, Landi F, Liperoti R. et al. Impact of inappropriate drug use among hospitalized older adults. Eur J Clin Pharmacol 2005; 61: 453-459
• 28 Gurwitz JH, Field TS, Avorn J. et al. Incidence and preventability of adverse drug events in nursing homes. Am J Med 2000; 109: 87-94
• 29 Dubrall D, Schmid M, Aleöik E. et al. Häufige Nebenwirkungen und als ursächlich verdächtigte Arzneimittelgruppen: Deskriptive Analyse der Spontanberichte in der Nebenwirkungsdatenbank des Bundesinstituts für Arzneimittel und Medizinprodukte (BfArM) von 1978 bis 2016. Dtsch Arztebl Int 2018; 115: 393-400